/ /

Ben Schwartz
Ben Schwartz is Associate Editor, Contemporary OB/GYN.
Study: Annual ob/gyn visits declining
Researchers note that the number of women who annually visit an ob/gyn has steadily declined since 2000. Plus: MAb may reduce risk of fracture in women with osteoporosis. Also, a study shows that postmenopausal hormone therapy is not associated with risk of all-cause, cardiovascular, or total cancer mortality.
How effective is the 9-valent HPV vaccine?
One study looks at how successful the 9vHPV vaccine is in preventing HPV-related cervical, vaginal, and vulvar diseases. Plus: FDA approves first neonatal MRI. Also, researchers note that obstetric services in rural areas severely lacking.
Uro Pipeline: Supplemental application submitted for advanced RCC treatment
Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.
New products: Holmium laser increases stone ablation volume
Other products discussed include cancer tests, an app to connect patients with specialists, a revenue management system, and more
Uro Pipeline: Phase IIb study begins for intraprostatic localized PCa drug
Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.
New Products: Nasal spray to treat nocturia receives FDA approval
Other products discussed include catheter sets to make the ordering process easier, a micro-US/MRI fusion application for prostate imaging, an international prostate registry for HIFU and more.
Uro Pipeline: FDA accepts two supplemental applications for mUC agent
Other pipeline developments include efficacy results for a bladder and prostate cancer drug, an infertility tool to predict sperm quality, the initiation of an immunotherapy combination for mUC, and more.
New Products: Two-in-one wire device combines access, safety guides
Other products discussed include an updated prostate tissue ablation device, a contrast agent for voiding ultrasonography, a bladder cancer test and more.
Uro Pipeline: FDA accepts biologics license application for bladder Ca agent
Other pipeline developments discussed include an implantable device for OAB treatment, a subcutaneous hypogonadism treatment, efficacy results for an HPV drug, and the status of a device-based BPH treatment.
Study: Compound found in vegetables could have anti-aging effects
A recent study found that the compound, NMN, boosts production of NAD+ in mice and could have anti-aging effects along with additional benefits, but more research is necessary to determine its effect on humans.

Poll